Scott A. Gerber, Ph.D.

Contact Information

Phone Numbers

Administrative: (585) 275-1488

Office: (585) 276-7380

Faculty Appointments

Associate Professor - Department of Surgery , Research (SMD)
Associate Professor - Cancer Center - Joint
Associate Professor - Department of Microbiology and Immunology (SMD) - Joint
Associate Professor - Department of Radiation Oncology (SMD) - Joint

Biography

Research

Dr. Gerber is a tumor immunologist whose laboratory focuses on harnessing the immune system to recognize and kill cancerous cells. His lab uses an immunotherapeutic approach to enhance the efficacy of chemo/radiotherapies to control or even cure both primary and metastatic malignancies.

Credentials

Education

1997
BS | SUNY Coll at Fredonia
Biology

2001
MS | University of Rochester School of Medicine & Dentistry
Immunology

2005
PhD | University of Rochester School of Medicine & Dentistry
Microbiology & Immunology

Post-doctoral Training & Residency

2005 - 2008
Yale University, New Haven, CT (Mentor: Jordan Pober)

Awards

2019
National Cancer Institute R01 CA230277

2019
URMC Outstanding Graduate Student Teacher Award

2018 - 2019
University Research Award

2018
Clinical and Translational Science Institute Pilot Study Award

2017
Wilmot Cancer Institute Collaborative Award

2016
Washington University SPORE in Pancreatic Cancer Developmental Research Award

2016
UR/UB Genomics Collaborative Pilot Award

2012 - 2013
American Association of Immunologist (AAI) Early Career Faculty Travel Grant

2008
Anna Fuller Fund Fellowship in Molecular Oncology
Sponsor: Yale University
Location: New Haven, CT

2006
Vincent du Vigneaud Award for outstanding doctoral thesis
Sponsor: University of Rochester Medical Center
Location: Rochester, NY

VIEW ALL

Publications

Journal Articles

10/8/2019
Mills BN, Connolly KA, Ye J, Murphy JD, Uccello TP, Han BJ, Zhao T, Drage MG, Murthy A, Qiu H, Patel A, Figueroa NM, Johnston CJ, Prieto PA, Egilmez NK, Belt BA, Lord EM, Linehan DC, Gerber SA. "Stereotactic Body Radiation and Interleukin-12 Combination Therapy Eradicates Pancreatic Tumors by Repolarizing the Immune Microenvironment." Cell reports.. 2019 Oct 8; 29(2):406-421.e5.

4/29/2019
Murthy A, Gerber SA, Koch CJ, Lord EM. "Intratumoral Hypoxia Reduces IFN-?-Mediated Immunity and MHC Class I Induction in a Preclinical Tumor Model." . 2019 Apr 29; 3(4):149-160. Epub 2019 Apr 29.

4/25/2019
MacDonald CR, Bucsek MJ, Qiao G, Chen M, Evans L, Greenberg DJ, Uccello TP, Battaglia NG, Hylander BL, Singh AK, Lord EM, Gerber SA, Repasky EA. "Adrenergic Receptor Signaling Regulates the Response of Tumors to Ionizing Radiation." Radiation research.. 2019 Apr 25; Epub 2019 Apr 25.

VIEW ALL PUBLICATIONS

Coronavirus (COVID-19): Visitor Restrictions, Resources, and Updates